packageGefitinib

gefitinib

Extends from Pharmacolibrary.Interfaces.PartialSubstance (Identity and physicochemical constants of one drug (Drugs.Substances)).

Information

Gefitinib is a tyrosine-kinase inhibitor used to treat non-small-cell lung cancer. It is an approved medicine, authorised in the European Union, and is also being studied for other uses.

Summary written by glm-5.3-flash from Wikidata Q417824 and the WHO ATC classification and the EMA medicines list; not checked by a person.

name:gefitinib
ATC codes:L01EB01, L01XE02
DrugBank:DB00317
PubChem CID:123631
ChEBI:49668
Wikidata:Q417824
formula:C22H24ClFN4O3
molar mass:446.907 g/mol (PubChem CID 123631)
logP:4.1 (Drugs.Common 25.09, not verified)

Parameters

TypeNameDefaultDescription
Stringname (from PartialSubstance)""INN / common name
String[:]atcCodes (from PartialSubstance)fill("", 0)all WHO ATC codes of the drug
StringdrugbankId (from PartialSubstance)""e.g. DB00758
StringpubchemCid (from PartialSubstance)""PubChem compound id
StringchebiId (from PartialSubstance)""ChEBI id (number)
StringwikidataId (from PartialSubstance)""e.g. Q410238
Stringformula (from PartialSubstance)""molecular formula
Modelica.Units.SI.MolarMassM (from PartialSubstance)0molar mass; 0 = unknown
ReallogP (from PartialSubstance)Modelica.Constants.infoctanol-water partition coefficient (log10); inf = unknown